Hospital mortality – Page 4 – Communicable Diseases Research

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

캐나다에서 COVID-19로 병원에 입원한 환자의 치료를 위한 Remdesivir: 무작위 대조 시험

Randomized Controlled Trial

Published on 2022-02-222022-09-11
Journal: CMAJ : Canadian Medical Association journal = jour [Category] COVID19(2023년), SARS, 임상, 치료제,

High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department

응급실에서 COVID-19 감염 환자의 집중 치료실 입원 및 사망률 증가와 관련된 높은 Procalcitonin 수준

Research Article

Published on 2022-02-212022-09-10
Journal: BMC Infectious Diseases [Category] COVID19(2023년), Fulltext, MERS, SARS, 바이오마커,

[키워드] 105 patient 105 patients 95% CI 95% confidence interval acute respiratory distress acute respiratory distress syndrome adjusted Admission age Analysis ARDS assist association AUC Bacterial bacterial coinfections Biomarker Biomarkers C-reactive protein C-reactive protein (CRP calculate center clinical decision Comorbidities Comorbidity Confirmed COVID-19 infection COVID-19 COVID-19 infection COVID-19 infections CRP D-dimer Decision making decision making process defined develop elevated emergency department Erasmus Final final analysis hospital discharge Hospital mortality hyperinflammation ICU ICU admission in-hospital mortality intensive care intensive care unit Logistic regression Mortality multivariable model Netherlands Odds ratio outcome Patient patients with COVID-19 PCT physician Primary outcome procalcitonin procalcitonin level reached required respiratory distress Respiratory distress syndrome Result retrospective cohort study Severe COVID-19 Infection severe COVID-19 infections Sex significantly supplementary material syndrome were measured
[DOI] 10.1186/s12879-022-07144-5 PMC 바로가기 [Article Type] Research Article

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study

COVID-19로 입원 한 환자를위한 덱사메타손과 함께 Remdesivir : 후 향적 다기관 연구

Multicenter Study

Published on 2022-02-172022-09-10
Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 치료제,

[키워드] 1:1 addition Admission Algorithm analyzed balance checked clinical benefit Combination COVID-19 pneumonia death death rate death rates Dexamethasone duration of hospitalization Hospital mortality Hospitalization hospitalized patient hospitalized patients In-hospital death in-hospital mortality Infectious disease Infectious diseases intensive care intensive care unit Logistic low-flow oxygen male Male sex matching mean differences median median time multivariable outcome oxygen Patient patients hospitalized patients with COVID-19 Pneumonia populations Primary outcome prognostic Propensity score receiving reduced Remdesivir replacement Result retrospective cohort study Retrospective multicenter study secondary Secondary outcomes Standard deviation Standard of care symptoms onset transfer Treatment was performed with COVID-19
[DOI] 10.1371/journal.pone.0262564 PMC 바로가기 [Article Type] Multicenter Study

Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival

중환자실 생존에 대한 비활성화된 SARS-CoV-2 백신(CoronaVac)의 효과

Original Paper

Published on 2022-02-092022-09-11
Journal: Epidemiology and Infection [Category] COVID19(2023년), MERS, SARS, 변종,

[키워드] Admission admitted to ICU arterial blood arterial blood gas Blood blood gas clinical CoronaVac coronavirus disease Coronavirus disease 2019 Course COVID-19 eligible enrolled evaluated ferritin ferritin level ferritin levels genetic variants group had no hospital Hospital mortality Hospital stay ICU inactivated intensive care intensive care unit investigated Laboratory Lactate lactate dehydrogenase Length Mortality National no effect not different on admission parameters Patient patients protective effect radiological Radiological parameters SARS-CoV-2 pandemic SARS-CoV-2 vaccine Sinovac survival target population vaccination vaccination schedule Vaccine
[DOI] 10.1017/S0950268822000267 PMC 바로가기 [Article Type] Original Paper

Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia

SARS-CoV2 관련 폐렴에서 인터루킨-6/림프구 비율의 예후 역할

Article

Published on 2022-02-012022-09-11
Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 바이오마커,

[키워드] 95% CI Admission age analyzed AUC Biomarker C-reactive protein collected COVID-19 COVID-19 patient CRP cytokine Cytokine storm D-dimer defined died dimer discharged Endpoint females fibrinogen High flow nasal cannula highest Hospital admission Hospital mortality Hospital stay ICU IL-6 in-hospital mortality independent Intensive intensive care unit interleukin interleukin-6 intubation invasive ventilation lymphocyte Lymphocytes material mean value Mortality multivariate multivariate logistic regression N/L nasal nasal cannula neutrophil no difference outcome Patient Pneumonia Prognosis prognostic required Respiratory failure SARS-CoV2 severe respiratory failure significantly higher significantly lower study population suffered tested
[DOI] 10.1016/j.intimp.2021.108435 PMC 바로가기 [Article Type] Article

Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test

긍정적 또는 음성 RT-PCR 검사를받은 Covid-19 환자의 뚜렷한 결과

Article

Published on 2022-01-182022-09-01
Journal: Viruses [Category] 진단,

[키워드] 28-day mortality Admission Clinical data conducted COVID-19 COVID-19 diagnosis COVID-19 infection COVID-19 testing diagnosing Diagnosis evidence of hospital Hospital mortality Hospital stay ICU identification in-hospital mortality increased risk intensive care intensive care unit intubation Laboratory mechanical ventilation Mortality Nasopharyngeal samples Nasopharyngeal swab nasopharyngeal swab sample negative negative RT-PCR outcome Participants Patient PCR test positive positive result positive RT-PCR Radiological Diagnosis radiological evidence RT-PCR RT-PCR test RT-PCR testing SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 virus Test the SARS-CoV-2 virus two groups were excluded
[DOI] 10.3390/v14020175 PMC 바로가기 [Article Type] Article

Obesity as a mortality risk factor in the medical ward: a case control study

의료 병동의 사망 위험 요인으로서의 비만 : 사례 관리 연구

Research Article

Published on 2022-01-062022-09-01
Journal: BMC Endocrine Disorders [Category] 진단,

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

염증 표지자를 기반으로 한 COVID-19에서의 코르티코스테로이드 또는 토실리주맙의 사용

Article

Published on 2022-01-012022-09-11
Journal: Journal of General Internal Medicine [Category] SARS, 바이오마커, 진단,

[키워드] administer Admission C-reactive protein cause of death collected Combination Corticosteroids COVID-19 COVID-19 patients CRP D-dimer values death in COVID-19 Efficacy Escalation evaluate ferritin HFNC high risk High-flow nasal cannula Hospital mortality ICU IMV in-hospital mortality inclusion criteria Inflammation inflammatory cascade intensive care intensive care unit Invasive mechanical ventilation Lactate lactate dehydrogenase LDH lower mortality lymphocyte Lymphocyte count mechanical ventilation Mortality nasal nasal cannula NIMV no significant differences Non-invasive non-invasive mechanical ventilation outcome Patient patients prescription Primary outcome propensity score matching registry retrospective cohort study Risk category secondary Secondary outcomes significant difference Spanish statistically significant TCZ therapy Tocilizumab treat treated Treatment
[DOI] 10.1007/s11606-021-07146-0 PMC 바로가기 [Article Type] Article

Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan

Covid-19를 가진 입원 환자의 사망 예측 자 : Kazakhstan, Nur-Sultan의 후 향적 코호트 연구

Research Article

Published on 2021-12-222022-09-10
Journal: PLoS ONE [Category] SARS, 바이오마커,

[키워드] activated activated partial thromboplastin time acute respiratory syndrome Admission age Anemia aPTT Asia C-reactive protein cardiac center coagulation test coagulation tests cohort study collected coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 CRP D-dimer demographic Descriptive statistics discharge disease onset elevated Factor ferritin Fever fibrinogen follow-up period Healthcare provider healthcare providers help high risk hospital Hospital mortality Hospitalization hospitalized patient hypoproteinemia identify In-hospital death in-hospital mortality increased respiratory rate independent predictor independent predictors infected patient infected patients Inflammatory marker inflammatory markers INR International international normalized ratio Kazakhstan Kidney function Kidney function tests Laboratory laboratory data Lactate lactate dehydrogenase large cohort Leukocytosis liver logistic regression models lower oxygen saturation lymphopenia males Mortality mortality rate multivariate logistic regression Non-survivors normalized Nur-Sultan outcome oxygen partial thromboplastin time Patient patients died patients with COVID-19 predict predictor provided reported respiratory respiratory rate Result retrospective cohort study risk factor Risk factors SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome-related coronavirus severe acute respiratory syndrome-related coronavirus 2 Support surgery Survivors the disease THROMBOPLASTIN variable were assessed were recorded with COVID-19
[DOI] 10.1371/journal.pone.0261272 PMC 바로가기 [Article Type] Research Article

Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System

Coronavirus Disease 2019 (COVID-19) 입원 : 미국의 대규모 미국 건강 시스템에서의 후 향적 코호트 연구의 만성 사용 및 임상 결과 사이의 연관성

Article

Published on 2021-12-062022-08-31
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료제,

[키워드] 95% CI 95% confidence interval Admission adults hospitalized chronic clinical Clinical outcome clinical outcomes cohort study coronavirus disease Coronavirus disease 2019 COVID-19 defined discharge drug entire cohort hazard ratio health system Hospital admission Hospital mortality Immunosuppressed Immunosuppression immunosuppressive drug immunosuppressive drugs IMPROVE in-hospital mortality individual interquartile range laboratory-confirmed mechanical ventilation mechanism median age Medicines mycophenolate mycophenolate mofetil no significant difference no significant differences Patient Prednisone prescription medicines. Prescriptions Probability Propensity score retrospective cohort study risk severity study period survived System tacrolimus the median Treatment with COVID-19
[DOI] 10.1093/cid/ciaa1488 PMC 바로가기 [Article Type] Article